• Skip to main content
  • Skip to footer

Life Sciences British Columbia

  • Newsletters |
  • Members Area |
  • Contact
  • SearchSearch
  • About
    • Board of Directors
    • Management
    • Vision & Mission
  • Awards
  • Membership
    • Sponsors
    • Members Directory
    • Members Area
    • Membership Benefits
    • Membership Discounts
    • Members Services
    • Members Map
    • Become a Member
  • Events
    • Calendar
    • Webinars
    • Past Events
      • 2023 Events
      • 2022 Events
      • 2021 Events
      • 2020 Events
      • 2019 Events
      • 2018 Events
  • News
    • All News
    • Member News
    • Industry News
    • LSBC in The News
    • Publications
    • BC Labour Market Study
  • Programs
  • Resources
    • All Resources
    • Grants and Funding
      • Funding Competitions
      • Wage Subsidies
    • Academic Institutions
    • Government
      • Federal
      • Provincial and Municipal
    • Association Partners
    • Volunteering
  • Jobs
    • Job Board
    • Post a Job
    • Career Events
  • Contact Us
  • Login

Sanofi Canada

Member Profile

Sanofi Canada creates lifechanging and lifesaving healthcare products. We are dedicated to advancing healthcare for the whole person and every person, with products that empower self-care, prevent and treat diseases and help people living with illnesses – whether temporary, rare or lifelong – to live better.

Today, we are one of Canada’s leading investors in life sciences, manufacturing and research and development. Our work is based on science that Canadians can trust and a commitment to meeting new challenges head on through innovation and partnership.

Backed by a strong heritage in Canada and a global network spanning 170 countries, we are proud to fight for millions of lives every day.

Sector
Global Pharmaceutical Corporations
Area of Expertise
  • Antibodies
  • Autoimmune Diseases
  • Cardiovascular Disease
  • Infectious Diseases
  • Inflammatory Diseases
  • Neurological Diseases
  • Oncology
  • Public Health
  • Therapeutics
  • Vaccines
Employees outside Canada 100,000+ employees
Stock Ticker SAN.PA - CAC40
Stock Ticker SNY - NYSE

Member Profile

Global Pharmaceutical Corporations

Sanofi Canada

Bronze Sponsor

  • Website www.sanofi.ca/en
  • Phone +1 (800) 265 7927
  • Email cainternet@sanofi.com
  • Address
    2905 Place Louis-R.-Renaud
    Laval, QC
    H7V 0A3
  • Leadership Contact
    Jon Fairest, President & CEO
    Follow us:
  • Twitter
  • LinkedIn
  • Instagram
  • News
  • Jobs

July 17, 2023

Dupixent® (dupilumab injection) Receives Marketing Authorization for Prurigo Nodularis

May 4, 2023

DUPIXENT® (dupilumab injection) is now Approved in Canada for the Treatment of Adult and Adolescent Patients (12+) With Eosinophilic Esophagitis

May 1, 2023

Libtayo® (cemiplimab) in Combination with Chemotherapy now approved in Canada for the First-line Treatment of Advanced Non-small Cell Lung Cancer

April 24, 2023

Health Canada Approves BEYFORTUS™ (nirsevimab) for the Prevention of RSV Disease in Infants

March 21, 2023

Notice of Compliance Issued Regarding Rezurock(TM) (belumosudil tablets)

No current content.

  • Twitter
  • Linkedin
Tweets by Sanofi Canada
Connect with us LinkedIn

© 2023 Life Sciences BC  |  Privacy Policy

  • Current Jobs
  • Event Calendar
  • All News
  • Member Directory
    Connect with us
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
Contact Us